Is BRRGF or RYLD a better dividend investment in 2026?

BRRGF currently yields 2.06% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between BRRGF and RYLD?

BRRGF has a forward dividend yield of 2.06% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 10.08 percentage points.

Home › Compare › BRRGF vs RYLD

BRRGF vs RYLD: Dividend Comparison 2026

BRRGF yields 2.06% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $21.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

BRRGF

● Live price

2.06%

Share price

$97.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.7K

Annual income

$235.33

Full BRRGF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — BRRGF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BRRGF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BRRGF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BRRGF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BRRGF

Annual income on $10K today (after 15% tax)

$175.09/yr

After 10yr DRIP, annual income (after tax)

$200.03/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $1,999.22/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BRRGF + RYLD for your $10,000?

BRRGF: 50%RYLD: 50%

100% RYLD50/50100% BRRGF

Portfolio after 10yr

$33.6K

Annual income

$1,411.34/yr

Blended yield

4.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BRRGF right now

BRRGF

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

2821.3

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BRRGF buys

RYLD buys

No recent congressional trades found for BRRGF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBRRGFRYLD

Forward yield	2.06%	12.14% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$22.7K	$44.5K ✓
Annual income after 10y	$235.33	$2,587.35 ✓
Total dividends collected	$2.2K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BRRGF vs RYLD ($10,000, DRIP)

Year	BRRGF Portfolio	BRRGF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$10,906	$205.99	$11,914	$1,213.65	$1.0K → RYLD
2	$11,879	$209.95	$14,099	$1,351.30	$2.2K → RYLD
3	$12,925	$213.73	$16,580	$1,494.55	$3.7K → RYLD
4	$14,047	$217.32	$19,384	$1,642.61	$5.3K → RYLD
5	$15,251	$220.74	$22,535	$1,794.70	$7.3K → RYLD
6	$16,542	$223.98	$26,063	$1,950.00	$9.5K → RYLD
7	$17,927	$227.05	$29,995	$2,107.69	$12.1K → RYLD
8	$19,412	$229.97	$34,361	$2,266.99	$14.9K → RYLD
9	$21,004	$232.72	$39,194	$2,427.12	$18.2K → RYLD
10	$22,709	$235.33	$44,525	$2,587.35	$21.8K → RYLD

BRRGF vs RYLD: Complete Analysis 2026

BRRGF — Stock

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, a bio-available small molecule AXL inhibitor, which is in Phase II clinical development in major cancer indications and COVID-19. Its Phase II clinical trial program focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as COVID-19. In addition, it is developing tilvestamab, an anti-AXL antibody that is in Phase Ib clinical trial. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Full BRRGF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this BRRGF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BRRGF vs SCHD BRRGF vs JEPI BRRGF vs O BRRGF vs KO BRRGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.